Jon Halbert insider trades
Open-market stock purchases and sales by Jon Halbert, Director at Caris Life Sciences, Inc, from SEC Form 4 filings since Feb 27, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +120%.
Companies traded
- CAI Caris Life Sciences, Inc: 1 buy, last Aug 14, 2026